Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1979 1
1980 2
1981 3
1982 1
1985 6
1986 3
1987 3
1988 5
1989 2
1990 3
1992 1
1993 6
1994 1
1995 3
1996 2
1997 4
1998 6
1999 9
2000 7
2001 4
2002 5
2003 7
2004 4
2005 8
2006 15
2007 13
2008 8
2009 12
2010 6
2011 4
2012 10
2013 12
2014 10
2015 11
2016 16
2017 18
2018 13
2019 29
2020 42
2021 38
2022 19
2023 17
2024 24
2025 27
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

386 results

Results by year

Filters applied: . Clear all
Page 1
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164.
Le DT, Kim TW, Van Cutsem E, Geva R, Jäger D, Hara H, Burge M, O'Neil B, Kavan P, Yoshino T, Guimbaud R, Taniguchi H, Elez E, Al-Batran SE, Boland PM, Crocenzi T, Atreya CE, Cui Y, Dai T, Marinello P, Diaz LA Jr, André T. Le DT, et al. Among authors: boland pm. J Clin Oncol. 2020 Jan 1;38(1):11-19. doi: 10.1200/JCO.19.02107. Epub 2019 Nov 14. J Clin Oncol. 2020. PMID: 31725351 Free PMC article. Clinical Trial.
Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164.
Le DT, Diaz LA Jr, Kim TW, Van Cutsem E, Geva R, Jäger D, Hara H, Burge M, O'Neil BH, Kavan P, Yoshino T, Guimbaud R, Taniguchi H, Élez E, Al-Batran SE, Boland PM, Cui Y, Leconte P, Marinello P, André T. Le DT, et al. Among authors: boland pm. Eur J Cancer. 2023 Jun;186:185-195. doi: 10.1016/j.ejca.2023.02.016. Epub 2023 Feb 24. Eur J Cancer. 2023. PMID: 37141828
Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study.
Bekaii-Saab TS, Ou FS, Ahn DH, Boland PM, Ciombor KK, Heying EN, Dockter TJ, Jacobs NL, Pasche BC, Cleary JM, Meyers JP, Desnoyers RJ, McCune JS, Pedersen K, Barzi A, Chiorean EG, Sloan J, Lacouture ME, Lenz HJ, Grothey A. Bekaii-Saab TS, et al. Among authors: boland pm. Lancet Oncol. 2019 Aug;20(8):1070-1082. doi: 10.1016/S1470-2045(19)30272-4. Epub 2019 Jun 28. Lancet Oncol. 2019. PMID: 31262657 Free PMC article. Clinical Trial.
Making Fluorouracil "Sexy" Again.
Boland PM, Hochster HS. Boland PM, et al. J Natl Cancer Inst. 2021 Apr 6;113(4):351-352. doi: 10.1093/jnci/djaa125. J Natl Cancer Inst. 2021. PMID: 32835362 Free PMC article. No abstract available.
Immunotherapy for Colorectal Cancer.
Boland PM, Ma WW. Boland PM, et al. Cancers (Basel). 2017 May 11;9(5):50. doi: 10.3390/cancers9050050. Cancers (Basel). 2017. PMID: 28492495 Free PMC article. Review.
Immunotherapy in colorectal cancer.
Agarwal P, Le DT, Boland PM. Agarwal P, et al. Among authors: boland pm. Adv Cancer Res. 2021;151:137-196. doi: 10.1016/bs.acr.2021.03.002. Epub 2021 Jun 7. Adv Cancer Res. 2021. PMID: 34148613 Review.
The sacral chordoma margin.
Radaelli S, Fossati P, Stacchiotti S, Akiyama T, Asencio JM, Bandiera S, Boglione A, Boland P, Bolle S, Bruland Ø, Brunello A, Bruzzi P, Campanacci D, Cananzi F, Capanna R, Casadei R, Cordoba A, Court C, Dei Tos AP, DeLaney TF, De Paoli A, De Pas TM, Desai A, Di Brina L, Donati DM, Fabbri N, Fiore MR, Frezza A, Gambarotti M, Gasbarrini A, Georg P, Grignani G, Hindi N, Hug EB, Jones R, Kawai A, Krol AD, Le Grange F, Luzzati A, Marquina G, Martin-Benlloch JA, Mazzocco K, Navarria F, Navarria P, Parchi PD, Patel S, Pennacchioli E, Petrongari MG, Picci P, Pollock R, Porcu L, Quagliuolo V, Sangalli C, Scheipl S, Scotto GM, Spalek M, Steinmeier T, Timmermann B, Trama A, Uhl M, Valverde C, Varga PP, Verges R, Weber DC, Zoccali C, Casali PG, Sommer J, Gronchi A. Radaelli S, et al. Among authors: boland p. Eur J Surg Oncol. 2020 Aug;46(8):1415-1422. doi: 10.1016/j.ejso.2020.04.028. Epub 2020 Apr 27. Eur J Surg Oncol. 2020. PMID: 32402509 Free article. Review.
Immune checkpoint inhibitors and vasculitis.
Boland P, Heath J, Sandigursky S. Boland P, et al. Curr Opin Rheumatol. 2020 Jan;32(1):53-56. doi: 10.1097/BOR.0000000000000672. Curr Opin Rheumatol. 2020. PMID: 31599800 Review.
386 results